MENU
+Compare
IRWD
Stock ticker: NASDAQ
AS OF
Jul 3 closing price
Price
$0.77
Change
+$0.03 (+4.05%)
Capitalization
1.36B

IRWD Ironwood Pharmaceuticals Forecast, Technical & Fundamental Analysis

Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment... Show more

IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for IRWD with price predictions
Jul 03, 2025

IRWD in -7.84% downward trend, declining for three consecutive days on June 30, 2025

Moving lower for three straight days is viewed as a bearish sign. Keep an eye on this stock for future declines. Considering data from situations where IRWD declined for three days, in of 289 cases, the price declined further within the following month. The odds of a continued downward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 56 cases where IRWD's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

IRWD broke above its upper Bollinger Band on June 10, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The Momentum Indicator moved above the 0 level on June 26, 2025. You may want to consider a long position or call options on IRWD as a result. In of 94 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

IRWD moved above its 50-day moving average on July 02, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for IRWD crossed bullishly above the 50-day moving average on July 02, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IRWD advanced for three days, in of 258 cases, the price rose further within the following month. The odds of a continued upward trend are .

The Aroon Indicator entered an Uptrend today. In of 154 cases where IRWD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. IRWD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.266) is normal, around the industry mean (62.462). P/E Ratio (10.309) is within average values for comparable stocks, (88.783). IRWD's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.913). Dividend Yield (0.000) settles around the average of (0.122) among similar stocks. P/S Ratio (3.027) is also within normal values, averaging (19.186).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. IRWD’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.

View a ticker or compare two or three
IRWD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

IRWD is expected to report earnings to fall 118.57% to 2 cents per share on August 07

Ironwood Pharmaceuticals IRWD Stock Earnings Reports
Q2'25
Est.
$0.03
Q1'25
Missed
by $0.10
Q4'24
Missed
by $0.04
Q3'24
Missed
by $0.05
Q2'24
Missed
by $0.17
The last earnings report on May 07 showed earnings per share of -14 cents, missing the estimate of -3 cents. With 1.03M shares outstanding, the current market capitalization sits at 1.36B.
A.I. Advisor
published General Information

General Information

a developer of innovative human medicines

Industry PharmaceuticalsOther

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
100 Summer Street
Phone
+1 617 621-7722
Employees
267
Web
https://www.ironwoodpharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
OCLGX14.040.15
+1.08%
Optimum Large Cap Growth C
SOCUX20.690.15
+0.73%
Spirit of America Utilities C
MDISX33.060.09
+0.27%
Franklin Mutual Global Discovery Z
VREQX10.450.01
+0.10%
NYLI CBRE Real Estate Class R6
FMFEX92.490.02
+0.02%
Fidelity Advisor Materials I

IRWD and Stocks

Correlation & Price change

A.I.dvisor tells us that IRWD and BGPPF have been poorly correlated (+24% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IRWD and BGPPF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IRWD
1D Price
Change %
IRWD100%
+3.56%
BGPPF - IRWD
24%
Poorly correlated
N/A
AMPH - IRWD
23%
Poorly correlated
-1.61%
DVAX - IRWD
22%
Poorly correlated
+1.08%
HKMPF - IRWD
22%
Poorly correlated
N/A
EOLS - IRWD
22%
Poorly correlated
+0.65%
More